SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-005884
Filing Date
2020-03-10
Accepted
2020-03-10 17:00:32
Documents
2
Period of Report
2020-03-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea119430-6k_chinasxt.htm 6-K 38366
2 EMPLOYMENT AGREEMENT BY AND BETWEEN PETER CHAN AND CHINA SXT PHARMACEUTICALS, IN ea119430ex99-1_chinasxt.htm EX-99.1 62134
  Complete submission text file 0001213900-20-005884.txt   101485
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 20702560
SIC: 2834 Pharmaceutical Preparations